Gemigliptin Market, By Type of Drug (Gemigliptin Monotherapy, Gemigliptin Combination Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics and Outpatient Facilities, Others), By Pat
Gemigliptin Market, By Type of Drug (Gemigliptin Monotherapy, Gemigliptin Combination Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics and Outpatient Facilities, Others), By Patient Demographics (Adult Population, Geriatric Population), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)
Gemigliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. With its unique chemical structure, gemigliptin effectively lowers blood glucose levels by enhancing the action of incretin hormones. This oral medication offers promising results in gycemic control by promoting glucose-dependent insulin secretion and suppressing glucagon release. As a newer entrant in the DPP-4 inhibitor class, Gemigliptin’s safety profile and efficacy make it a valuable option for diabetes patients seeking improved glucose regulation and a reduced risk of hypoglycaemia. This medication is characterized by its unique chemical structure and mechanism of action, setting it apart from other antidiabetic drugs. Gemigliptin is typically prescribed as a once-daily oral treatment, providing convenience for patients managing their diabetes. However, ongoing research, strategic marketing, and potential innovations in formulation or combination therapies aim to position gemigliptin as a valuable option in the diverse landscape of diabetes management.
Market Dynamics:
The rising prevalence of diabetes, increasing awareness and diagnosis, and shift towards oral antidiabetic drugs are anticipated to drive growth of the global gemigliptin market over the forecast period. Moreover, a favorable regulatory environment is also expected to boost the growth of the global gemigliptin market over the forecast period. Expansion in emerging markets, combination therapies, a focus on patient-centric approaches, pediatric use, and gestational diabetes are expected to create growth opportunities for the global gemigliptin market during the forecast period.
However, competition from established drugs, patent expiry, generic competition, and safety concerns are expected to hamper growth of the gemigliptin market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the gemigliptin market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the gemigliptin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Daewoong Pharmaceutical, Sanofi, LG Chem, Hanmi Pharmaceutical Co., Ltd., and Merck
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The gemigliptin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the gemigliptin market
Detailed Segmentation:
Gemigliptin Market Segmentation, By Type of Drug:
Gemigliptin Monotherapy
Gemigliptin Combination Therapy
Gemigliptin Market Segmentation, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Gemigliptin Market Segmentation, By End User:
Hospitals
Clinics and Outpatient Facilities
Others (Academic and Research Institutes)
Gemigliptin Market Segmentation, By Patient Demographics:
Adult Population
Geriatric Population
Gemigliptin Market Segmentation, By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profile:
Daewoong Pharmaceutical
Sanofi
LG Chem
Hanmi Pharmaceutical Co., Ltd.
Merck
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Gemigliptin , By Type of Drug
Market Gemigliptin , By Distribution Channel
Market Gemigliptin , By End User
Market Gemigliptin , By Patient Demographics
Market Gemigliptin , By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Rising prevalence of diabetes
Restraints
Competition from established drugs
Opportunities
Expansion in emerging markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Gemigliptin Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Gemigliptin Market , By Type of Drug, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Gemigliptin Monotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gemigliptin Combination Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Gemigliptin Market , By Distribution Channel, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Gemigliptin Market , By End User, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Clinics and Outpatient Facilities
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others (Academic and Research Institutes)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
8. Gemigliptin Market , By Patient Demographics, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Adult Population
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Geriatric Population
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
9. Gemigliptin Market , By Region, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2019-2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Daewoong Pharmaceutical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
LG Chem
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hanmi Pharmaceutical Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Gemigliptin Market” - Global forecast to 2030